SADDLE RIVER, N.J.--(BUSINESS WIRE)--PDI, Inc. (NASDAQ: PDII), a pioneer in providing contract sales and commercial services to the biopharmaceutical industry, today announced that it has posted on its web site at www.pdi-inc.com the following letter to stockholders from its new chief executive officer, Nancy Lurker.
